April 29, 2022 Comments Off on New patent expiration for Astrazeneca drug LYNPARZA Posted in: Uncategorized
Annual Drug Patent Expirations for LYNPARZA Lynparza is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eleven patents protecting…
The post New patent expiration for Astrazeneca drug LYNPARZA app…
April 29, 2022 Comments Off on New patent for Am Regent drug INJECTAFER Posted in: Patent Added Annual Drug Patent Expirations for INJECTAFER Injectafer is a drug marketed by Am Regent and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent for Am Regent drug INJECTAFER appeared first on DrugPate…
